Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Nelson

Showing results (301-310 of 442) with videos related to

Pageof 45
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Different methods to calculate the inhibitory quotient of boosted single protease inhibitors and their association with virological responseAlan Winston, Nimesh Patel, David Back, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individualsMartin Vogel, Emma Page, Christoph Boesecke, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 29, 2017
Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysisRichard Ofori-Asenso, Avtar Jakhu, Ella Zomer, et al.
Antiviral Therapy|October 12, 2007
HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activationAlan Steel, Alison E Cox, Mohamed H Shamji, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2010
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART)Loveleen Bansi, Anna Maria Geretti, David Dunn, et al.
The Pharmacogenomics Journal|April 9, 2025
Meta-analysis and review of in silico methods in drug discovery - part 1: technological evolution and trends from big data to chemical spaceArife Uzundurukan, Mark Nelson, Christopher Teske, et al.
AIDS (London, England)|January 26, 2017
Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavirSophie Jose, Mark Nelson, Andrew Phillips, et al.
AIDS (London, England)|November 7, 2006
Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infectionEduardo Lissen, Nathan Clumeck, Ricardo Sola, et al.
BMJ Open|September 10, 2013
Effects of telephone health mentoring in community-recruited chronic obstructive pulmonary disease on self-management capacity, quality of life and psychological morbidity: a randomised controlled trialJulia Walters, Helen Cameron-Tucker, Karen Wills, et al.
Journal of the International AIDS Society|November 15, 2014
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failureAnna Schultze, Roger Paredes, Caroline Sabin, et al.
Pageof 45

Showing results (301-310 of 442) with videos related to

Sort By:
Pageof 45
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Different methods to calculate the inhibitory quotient of boosted single protease inhibitors and their association with virological responseAlan Winston, Nimesh Patel, David Back, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individualsMartin Vogel, Emma Page, Christoph Boesecke, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 29, 2017
Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysisRichard Ofori-Asenso, Avtar Jakhu, Ella Zomer, et al.
Antiviral Therapy|October 12, 2007
HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activationAlan Steel, Alison E Cox, Mohamed H Shamji, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2010
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART)Loveleen Bansi, Anna Maria Geretti, David Dunn, et al.
The Pharmacogenomics Journal|April 9, 2025
Meta-analysis and review of in silico methods in drug discovery - part 1: technological evolution and trends from big data to chemical spaceArife Uzundurukan, Mark Nelson, Christopher Teske, et al.
AIDS (London, England)|January 26, 2017
Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavirSophie Jose, Mark Nelson, Andrew Phillips, et al.
AIDS (London, England)|November 7, 2006
Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infectionEduardo Lissen, Nathan Clumeck, Ricardo Sola, et al.
BMJ Open|September 10, 2013
Effects of telephone health mentoring in community-recruited chronic obstructive pulmonary disease on self-management capacity, quality of life and psychological morbidity: a randomised controlled trialJulia Walters, Helen Cameron-Tucker, Karen Wills, et al.
Journal of the International AIDS Society|November 15, 2014
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failureAnna Schultze, Roger Paredes, Caroline Sabin, et al.
Pageof 45